The present invention relates to FMDC vaccine based on peptides having a sequence
of at least 8 amino acids, which corresponds to a partial sequence of the non-structural
protein region of FMDV, which was selected by immunoreactivity with FMDV-specific
antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their
production and their use.